Targeted News Service

JAMA Cardiology Letter Highlights Limitations and Risks of Semaglutide
May 14, 2025

WASHINGTON, May 14 [Category: Health Care] -- Physicians Committee for Responsible Medicine posted the following news release:

* * *

JAMA Cardiology Letter Highlights Limitations and Risks of Semaglutide

WASHINGTON, D.C.--Limited effectiveness, weight regain, and high prevalence of adverse events are the three key limitations of semaglutide highlighted in a letter published in the Journal of the American Medical Association (JAMA) Cardiology. The letter is . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your Affiliation	Government Newspaper / Media Business Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions or comments:

Click here for more information about our products

Existing Customer Login

Targeted News Service Document Request Form